Cat. No.: X23-10-ZQ483
Aurora kinase inhibitor SCH-1473759, Purity ≥98%
Synonym: 1094069-99-4; SCH-1473759; 2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol; SCH 1473759; CHEMBL1232515; 2-{Ethyl[(5-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}isothiazol-3-yl)methyl]amino}-2-methylpropan-1-ol; 2-{Ethyl[(5-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}-1,2-thiazol-3-yl)methyl]amino}-2-methylpropan-1-ol; Aurora kinase inhibitor
- CAS Number: 1094069-99-4
- Compound CID: 25144732
Product Size
2 mg; 5 mg; 10 mg; 25 mg
Properties
Description
SCH-1473759 is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A and Aurora B.
Molecular Formula
C20H26N8OS
Targets
Aurora A: 4 nM; Aurora B: 13 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
SCH-1473759 can be used to analyze the effects of Aurora kinase inhibition in cancer models.
Related Products
